Based on the company’s core technology platform for bioinfo gathering and AI analysis, Nobotics will bring immediate decision-support to the pediatrician’s office helping to discern between ear infections that are bacterial in nature and those that are viral. The product is expected to improve care by accelerating treatment and avoiding unnecessary prescription and use of antibiotics.
* PressureSafe is not yet available for commercial use. Expected US launch: H1/2024
© 2023 IR-Med Inc., PressureSafe and Nobotics are trademarks of IR-MEd, Inc. All rights reserved.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.